# FDA Inspection 1194602 - Baylor Scott and White McLane Children's Medical Center - December 07, 2022

Source: https://www.keypedia.com/records/fda_inspections/baylor-scott-and-white-mclane-childrens-medical-center/767166dd-9f7f-4841-aa5d-c2ae2d70821f
Source feed: FDA_Inspections

> FDA Inspection 1194602 for Baylor Scott and White McLane Children's Medical Center on December 07, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1194602
- Company Name: Baylor Scott and White McLane Children's Medical Center
- Inspection Date: 2022-12-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1312682 - 2026-04-07](https://www.keypedia.com/records/fda_inspections/baylor-scott-and-white-mclane-childrens-medical-center/0e8a3fe2-4e47-4e01-86e0-5c41f76c2edd)
- [FDA Inspection 1194602 - 2022-12-07](https://www.keypedia.com/records/fda_inspections/baylor-scott-and-white-mclane-childrens-medical-center/a92df8f4-eae9-4970-b267-f2062ff7d7cb)

Company: https://www.keypedia.com/companies/baylor-scott-and-white-mclane-childrens-medical-center/2ace9102-7d35-4eed-9c28-3b8f53060bb4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d